ASHP InterSections ASHP InterSections

April 13, 2017

Celebrating Former ASHP CEOs: Henri R. Manasse Jr., Ph.D., Sc.D. (Hon.), FFIP

Paul W. Abramowitz, Pharm.D., Sc.D. (Hon.), FASHP

AS PART OF ASHP’s yearlong 75th anniversary celebration, I will be recognizing our three former Chief Executive Officers: Drs. Henri R. Manasse Jr., Joseph A. Oddis, and Gloria Francke. This blog will recognize our most recent CEO, Dr. Manasse, who served ASHP from 1997 to 2011.

Dr. Manasse came to ASHP after a long and illustrious career as a leader in academic healthcare. He was Vice President for Health Sciences at The University of Iowa and Chairman of the Board of the University of Iowa Health System. Prior to that, he was interim Vice Chancellor for Health Services at the University of Illinois at Chicago Medical Center, and Dean and Professor of Pharmacy Administration at the University of Illinois at Chicago College of Pharmacy. In 1988 he served as president of the American Association of Colleges of Pharmacy. He is also a member of the prestigious National Academy of Medicine (formally the Institute of Medicine) of the National Academy of Sciences and a recipient of pharmacy’s highest honor, the Harvey A.K. Whitney Lecture Award.

Dr. Manasse came to ASHP during a time of transition and change, and he helped the society become an even more outward-facing organization. Under his leadership, ASHP became increasingly engaged in proactive government advocacy and formed strong relationships with a wide variety of stakeholders in medicine, nursing, standards-setting bodies, hospital organizations, payers, and many others. He played a vital role after the 1999 Institute of Medicine Report, “To Err is Human,” to take ASHP’s longtime focus on patient safety, and work with stakeholders in all segments of society to help drive fundamental changes that have helped improve patient safety throughout the entire healthcare system.

In 2006 he served as Chair of the Board of Governors of the National Patient Safety Foundation and co-chaired the Safe Practices Steering Committee and the Advisory Committee for Executive Leadership of the National Quality Forum. He also chaired The Joint Commission’s Sentinel Event Alert Advisory Committee and served on the U.S. Food and Drug Administration’s Drug Safety and Risk Management Advisory Committee. In 2005, he was elected as the Professional Secretary of the Board of Pharmaceutical Practice of the International Pharmaceutical Federation. He also served on the Board of Advisors of the Association of Academic Health Centers project on the Future of the Health Professions Work Force.

Dr. Manasse’s time as CEO was also a period of growth for ASHP in numerous areas including membership, educational conferences, residency accreditation, publishing, and many others. He also oversaw the formation of many of ASHP’s highly successful pharmacy practice sections and forums, which include the Sections of Clinical Specialists and Scientists, Ambulatory Care Practitioners, Pharmacy Informatics and Technology, Inpatient Care Practitioners, Pharmacy Practice Managers, and the Student and New Practitioners Forums.

Henri was and still is a strong advocate for the leadership roles that pharmacists play as direct patient care providers. He has been a longtime advocate for the enhanced roles that educated, PTCB certified, and licensed pharmacy technicians must play to ensure that all patients have access to a pharmacist on the interprofessional team who is responsible for their medication therapy. Dr. Manasse has dedicated his nearly 50-year career to continuously elevating the entire pharmacy profession with the singular goal of ensuring that medication use is optimal, safe, and effective for all people all of the time.

I had the pleasure of chairing the ASHP CEO Search Committee that led to Dr. Manasse’s selection and later serving as Treasurer of ASHP during Henri’s time as CEO. Our time together and ongoing friendship is something that I will always value. Henri is a true leader and has been a mentor to countless pharmacists, student pharmacists, ASHP staff members, board members, and many others.

As we celebrate ASHP’s 75th anniversary, please join me in thanking Dr. Manasse for his exceptional contributions to ASHP and to the entire pharmacy profession.



March 27, 2017

ASHP’s 75th Anniversary: Celebrating the Past, Creating the Future

Paul W. Abramowitz, Pharm.D., Sc.D. (Hon.), FASHP

ASHP TURNS 75 THIS YEAR, and we have a yearlong campaign filled with surprises and exciting events for our members to celebrate this significant milestone. The last 75 years have been marked by so many ASHP-led advances in pharmacy practice, including: the creation of postgraduate residency training, clinical pharmacy, enhanced recognition of pharmacists as vital members of the interprofessional team, the largest gathering of pharmacists in the world — the ASHP Midyear Clinical Meeting — and so many more.

Although much has been accomplished over the last 75 years, our focus remains on the future, and ensuring that more and more people have access to the direct patient care services of pharmacists. Therefore, the theme of our yearlong celebration is Celebrating the Past, Creating the Future.

The founders of ASHP were visionaries who understood and learned from the past but realized that pharmacists must transform their practices. They worked hard to create a practice future designed to dramatically improve the care of their patients. These leaders included legends such as Gloria Niemeyer Francke, ASHP’s first CEO; Harvey A.K. Whitney, ASHP’s first president; and Donald Francke, ASHP’s second president; and, of course, Joseph A. Oddis, ASHP’s CEO for over 37 years. These are just a few of the great leaders who realized very early that pharmacists must do so much more than dispense drugs, and that ASHP should be the organization that makes it happen on behalf of patients.

Prior to the 1920s, hospital pharmacy was not a strong, well-organized component of the profession. In 1936, a subsection of hospital pharmacists in APhA was formed and, for the first time, hospital pharmacists had a voice on the national pharmacy stage. In 1942, the American Society of Hospital Pharmacists was formed with 153 charter members who worked exclusively in hospital settings.

Today ASHP has nearly 45,000 members who treat patients in every healthcare setting, including in ambulatory clinics, hospitals, and throughout the entire continuum of patient care. ASHP members are involved in all facets of pharmacy practice and include inpatient pharmacists, ambulatory care pharmacists, clinical specialists and scientists, informatics experts, practice managers, student pharmacists, residents, new practitioners, pharmacy technicians, and others.

We owe our success to our dedicated members, which is why we would like you to help us celebrate our diamond anniversary. We have a number of special activities scheduled throughout the year, culminating in a grand finale celebration at the Midyear Clinical Meeting in Orlando in December. We also are planning significant activities for key ASHP events including the Summer Meetings in June, the Preceptors Conference in August, Policy Week in September, and the Leaders Conference in October.

Thank you so much for being a member of ASHP, and for everything you do for your patients. With your help, we can continue to improve patient care and support you in your professional endeavors.

Please join us in celebrating this important anniversary — and stay tuned for more details as we roll out our 75th anniversary celebration.



December 20, 2011

From the President

Stan Kent, M.S., FASHP

In my position as ASHP president, I often hear from members about their thoughts on the current state of pharmacy practice. One of the things I’m hearing a lot lately is how tough the job market is for new graduates.

I wanted to get a better handle on just what was going on out there, so ASHP fielded a job market survey in August targeted to pharmacy students and new practitioners. More than 2,000 ASHP members responded, and we found some interesting trends.

The survey revealed that 2011 pharmacy school graduates started their job searches earlier and applied for more positions and residencies than peers who graduated in previous years. It also found that 2011 graduates who found a residency position made compromises more than previous graduates with regard to location, salary and hours worked.

This issue of InterSections focuses on the tightening job market, which has a number of causal factors, including a stagnated economy, the rapidly expanding number of pharmacy schools, and more pharmacists who are delaying retirement.

The story provides some great advice about what students and new practitioners can do to position themselves for success, including doing residencies, looking for jobs in more rural areas, and getting involved in ASHP as a way to expand their professional networks.

One of the most important events to happen at ASHP in 15 years will occur at the end of December with the retirement of ASHP’s CEO and Executive Vice President Henri R. Manasse, Jr., Ph.D., Sc.D. As only the third EVP in ASHP’s 69-year history, Henri has done incredible things for the organization’s influence on medication-related health care policy, practice-model change, and our Society’s national and international reputation. InterSections sat down with Henri to hear his thoughts on the biggest challenges he faced during his years as CEO and what he hopes for the future.

As an accompaniment, we also interviewed ASHP’s new CEO and Executive Vice President Paul Abramowitz, Pharm.D., FASHP, about what he sees for the immediate and long-term future for both ASHP and health-system pharmacy practice. As an ASHP past president, former member of ASHP’s Board, and former treasurer, Paul brings a deep understanding of the needs of ASHP members to the job. And Paul’s 34 years in health system pharmacy practice as both a practitioner and administrator affords him an incredibly astute perspective on current practice.

Practice change is taking off at hospitals and health systems across the country, and we have two stories in this issue that reflect new modes of pharmacy practice.

The first, “ASHP State Affiliates Taking PPMI to Next Level,” shows how states like Michigan, Wisconsin and Utah are leading the way on the Pharmacy Practice Model Initiative (PPMI). It’s an exciting start to a national journey that will ensure pharmacists become the health care professionals who are responsible for their patients’ medication-related outcomes.

The second story focuses on innovative technician roles in hospitals in Minnesota and Washington.

As always, InterSections strives to cover and address the challenges you face in practice each day and be an inspirational resource for you to tap into. Enjoy!

 Stan Kent, M.S., FASHP

December 1, 2008

First Educate…Then Advocate

Filed under: Uncategorized — Tags: , , , — admin @ 4:52 pm

            You’ll notice on the next page a series of pictures of ASHP ’s recent Legislative Day, Sept. 27. In all, members held more than 100 meetings with Congress members and their legislative staff to educate them on pharmacists’ critical patient-care role.

            Members started early, with a breakfast meeting featuring Leigh Ann Ross, a pharmacist and healthcare legislative assistant in the office of Sen. Thad Cochran (R-Miss.). And they finished late—tired but excited to have connected with key decision makers.

            It’s an exhausting day—not just because of the long hours, but because we ask members to step far outside of their comfort zones. We ask them to be ready to talk about the Society’s legislative priorities and to transform themselves into lobbyists for a day. And it works! Because of what our members do each year, and the continual work of our government affairs staff, Congress is more aware of the ways in which pharmacists improve patient care.

            Whether you’re walking the halls of Congress or inviting a local representative into your hospital to observe how your pharmacy works, I believe it’s vital to educate, then advocate. I also believe that effective advocacy starts with certain assumptions, including that:

  • One person with an idea can initiate change,
  • Most legislators want to positively affect the lives of their constituents (aka your patients), and
  • Legislators are not well-versed in medication use, patient safety, pharmacists’ changing roles, or health-system pharmacy professional issues.

It’s up to all of us to educate decisionmakers, including our elected officials, about the best care for patients.

September 1, 2008

Helping Technicians Fulfill a Stronger Role

            Safe, effective medication use is predicated on ensuring that everyone on the pharmacy team works at the same level of excellence. In addition to pharmacists, that includes pharmacy technicians, who are the backbone of much of what we do. We need technicians to take on even more if we hope to step out of the pharmacy and onto the patient-care floors.

            Unfortunately, pharmacy technicians are one of only a few positions in healthcare for which there is no standardized training. Yet in order for technicians to play an even greater role as part of the pharmacy team, pharmacists must insist on appropriate technician education, training, and certification.

            ASHP’s position is that all pharmacy technicians should complete ASHP-accredited training programs, be certified by the Pharmacy Technician Certification Board, and be registered by state boards of pharmacy.

            Getting that done won’t happen overnight. And it can only happen with the help of our members.

            So, we are asking all of our state affiliates to partner with us on a new Pharmacy Technician Initiative. Under the program, each affiliate will work with us to assess existing regulations, existing state-based training programs, and other local factors. In turn, we will help develop a legislative action plan for each affiliate and offer support via the new Pharmacy Technician Initiative resource center on ASHP’s Web site.

            As of publication time, affiliates from the states of California, Florida, Georgia, Illinois, Indiana, Kansas, Michigan, Mississippi, New York, South Carolina, and Wyoming have agreed to join with us.

            Stay tuned as we move this exciting effort forward—we’re eager to work with the leaders of each affiliate as we improve the abilities of our pharmacy technician workforce.

June 1, 2008

Getting to the Root of IV Medication Errors

            In November 2007, an intravenous medication error that could have been fatal for the newborn twin daughters of actor Dennis Quaid and his wife Kimberly occurred. Sadly, this event is only the latest in a series of recent errors that injured or killed a child. Part of the tragedy of these events is that we, as healthcare providers, continue to ignore the lessons that should have been learned.

            Even though several of these errors occurred with medications that have now been re-labeled, the contributory factors remain. Non-standardization; poorly designed, incomplete, or ambiguous labeling; unsafe storage practices; and inadequately trained or supervised personnel—all are part of a IV medication-use system that must be overhauled.

            The biomedical literature is replete with research on the causes of IV medication errors and successful preventive strategies, some of which have been used effectively. But this knowledge has not made a lasting, sustainable change in the way hospitals and health systems work; in packaging, labeling, and equipment design improvements; or in the creation of new mandatory regulatory or quality standards.

            So, ASHP is stepping into the gap to bring about fundamental, lasting change. Together with the ASHP Research and Education Foundation, we are calling together key players July 14–15 to an IV Safety Summit to study this issue in depth and seek new solutions.

            Panelists include nationally renowned experts like medication-safety advocate David Bates, M.D., with Brigham and Women’s Hospital; Carolyn Clancy, M.D., with the Agency for Healthcare Research and Quality; and Gerald J. Dal Pan, M.D., director of the Office of Drug Safety for the FDA. Other participants include representatives from healthcare professional associations, industry, federal agencies, safety and quality oversight groups, and human factors experts.

            Together, we will examine current evidence on the causes of intravenous errors, such as clinical issues, human factors, process design, and technology, as well as effective error-prevention methods. Our goal is action that will create sustainable changes in our hospitals and health systems. It’s time to put an end to IV medication errors, once and for all.

Older Posts »

Powered by WordPress